FDA Approves Monoclonal Antibody To Treat COVID-19 For First Time
Authored by Mimi Nguyen Ly via The Epoch Times (emphasis ours), The U.S. Food and Drug Administration (FDA) has, for the first time, approved a monoclonal antibody to treat COVID-19 in hospitalized patients. Healthcare company Roche’s Actemra (tocilizumab) intravenous (IV) was approved by the FDA to treat severe COVID-19 in adults, the company announced on Wednesday. Specifically, the drug … Continue reading FDA Approves Monoclonal Antibody To Treat COVID-19 For First Time
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed